Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Free Cash Flow (Quarterly): -19.00M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -19.00M |
| June 30, 2023 | -19.90M |
| March 31, 2023 | -23.22M |
| December 31, 2022 | -14.18M |
| September 30, 2022 | -21.33M |
| June 30, 2022 | -18.69M |
| March 31, 2022 | -18.58M |
| December 31, 2021 | -13.46M |
| Date | Value |
|---|---|
| September 30, 2021 | -9.341M |
| June 30, 2021 | -12.43M |
| March 31, 2021 | -4.316M |
| December 31, 2020 | -3.689M |
| September 30, 2020 | -2.442M |
| June 30, 2020 | -4.54M |
| March 31, 2020 | -3.548M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-23.22M
Minimum
Mar 2023
-2.442M
Maximum
Sep 2020
-12.58M
Average
-13.46M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -111.86M |
| Immunogen Inc (DELISTED) | 1.416M |
| AbbVie Inc | 3.847B |
| Assure Holdings Corp | -0.222M |
| Harpoon Therapeutics Inc (DELISTED) | -16.62M |